| <img alt="" height="1" width="1" />Salix Pharma Announces NDA Submission For XIFAXAN550 - Quick FactsStock Markets Review... for XIFAXAN (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome and IBS-related bloating. ...<nobr>and more »</nobr> |
Google- Salix Pharma Announces NDA Submission For XIFAXAN550 - Quick Facts - Stock Markets Review
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!